A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20mg/day for the treatment of patients with acute exacerbations of schizophrenia-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20mg/day for the treatment of patients with acute exacerbations of schizophrenia

Published:2007-12 Issue:11 Volume:41 Page:895-905
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

McEvoy Joseph P.,Daniel David G.,Carson William H.,McQuade Robert D.,Marcus Ronald N.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference17 articles.

1. Consensus development conference on antipsychotic drugs and obesity and diabetes;ADA/APA/AACE/NAASO;Diabetes Care,2004

2. An analysis of the time relations of electrocardiograms;Bazett;Heart,1920

3. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine;Chrzanowski;Psychopharmacology (Berl),2006

4. Neurocognitive effects of aripiprazole versus olanzapine in stable psychosis;Cornblatt;International Journal of Neuropsychopharmacology,2002

5. The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia;Cutler;CNS Spectrums,2006

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure–Response Modeling in Adults and Adolescents With Schizophrenia to Support the Extrapolation of Brexpiprazole Efficacy to Adolescents;The Journal of Clinical Pharmacology;2024-07-08

2. Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid Review;Biomedicines;2023-03-16

3. Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia;The Journal of Clinical Psychiatry;2023-02-08

4. Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis;International Journal of Neuropsychopharmacology;2022-05-31

5. Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trials;Neuroscience & Biobehavioral Reviews;2022-04